Filing Details
- Accession Number:
- 0001062993-22-019645
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-19 07:00:11
- Reporting Period:
- 2022-09-16
- Accepted Time:
- 2022-09-19 07:00:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1374690 | Larimar Therapeutics Inc. | LRMR | Pharmaceutical Preparations (2834) | 203857670 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1529611 | Carole Ben-Maimon | C/O Larimar Therapeutics, Inc. Three Bala Plaza East, Suite 506 Bala Cynwyd PA 19004 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-16 | 31,746 | $3.15 | 56,829 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on September 16, 2022.
Billionaire Hedge Funds
